The healthcare expenditure on pharmacies in Poland for 2023 was 6.93 billion Euros. Moving forward, the forecasted values indicate a steady increase: 7.01 billion Euros in 2024, 7.11 billion Euros in 2025, climbing to 7.37 billion Euros by 2028. This reflects a consistent upward trend, with a year-on-year growth rate around 1.4% for 2024, 1.42% for 2025, 1.27% for 2026, and 1.25% for 2027. The Compound Annual Growth Rate (CAGR) for the period from 2023 to 2028 is estimated to be approximately 1.23%.
Future trends to watch include the potential impact of digital health initiatives, changes in regulatory policies, the introduction of innovative pharmaceutical products, and the influence of demographic shifts, such as the aging population. These factors could significantly affect healthcare expenditure in the coming years.
Latest reports
US Erectile Dysfunction Market Report- Q1 2025
The US Erectile Dysfunction (ED) market in Q1 2025 is navigating a challenging economic landscape marked by inflationary pressures, geopolitical tensions, and a...
South Korea Erectile Dysfunction Market Report- Q4 2024
The South Korean Erectile Dysfunction (ED) market in the fourth quarter of 2024 is characterized by evolving consumer preferences, technological innovations, and economic...
Spain Erectile Dysfunction Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic period for the Erectile Dysfunction (ED) market in Spain, marked by significant developments and emerging...
